UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

|X| QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934


                For the quarterly period ended September 30, 2006


|_| TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


               For the transition period from ______ to __________

                        Commission File Number : 0-27569

                             NATURAL NUTRITION, INC.
        (Exact name of small business issuer as specified in its charter)

                 Nevada                                  65-0847995
    ---------------------------------         ---------------------------------
      (State or other jurisdiction            (IRS Employer Identification No.)
    of incorporation or organization)

                       109 North Post Oak Lane, Suite 422
                                Houston, TX 77024
--------------------------------------------------------------------------------
                    (Address of principal executive offices)

                                 (713) 621-2737

 Date: November 14, 2006                       Natural Nutrition, Inc.

                           (Issuer's telephone number)

                      (Formerly CSI Business Finance, Inc.)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes |X| No |_|

Indicate by check whether the  registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes |_|   No |X|

The number of shares  outstanding  of our common  stock at  November 3, 2006 was
11,587,693.

Transitional Small Business Disclosure Format (check one):   Yes: |_|  No: |X|


                                     - 1 -
--------------------------------------------------------------------------------
<PAGE>

                             NATURAL NUTRITION, INC.

                                   FORM 10-QSB


                                      INDEX

                                                                          Number

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements
Condensed Consolidated Balance Sheet as of September 30, 2006
  (Unaudited)                                                               3
Condensed Consolidated Statements of Operations for the three
  months ended September 30, 2006 and 2005 (Unaudited)                      4
Condensed Consolidated Statements of Operations for the nine
  months ended September 30, 2006 and 2005 (Unaudited)                      5
Condensed Consolidated Statements of Cash Flows for the nine
  months ended September 30, 2006 and 2005 (Unaudited)                      6
Notes to Condensed Consolidated Financial Statements (Unaudited)          7 - 9
Item 2. Management's Discussion and Analysis or Plan of Operation         9 - 13
Item 3. Controls and Procedures                                          13 - 14

PART II - OTHER INFORMATION

Item 1. Legal Proceedings                                                  15
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds        15
Item 3. Defaults Upon Senior Securities                                    15
Item 4. Submission of Matters to a Vote of Security Holders                15
Item 5. Other Information                                                  15
Item 6. Exhibits                                                           15

SIGNATURES                                                                 16



                                     - 2 -
--------------------------------------------------------------------------------
<PAGE>

PART I -FINANCIAL INFORMATION

Item 1.  Financial Statements

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                      CONDENSED CONSOLIDATED BALANCE SHEET
                               September 30, 2006
                                   (Unaudited)

                                     ASSETS
CURRENT ASSETS
  Cash                                                             $  1,640,242
  Deferred financing costs                                              191,665
  Notes receivable                                                    1,433,386
  Note receivable - related party                                       275,000
  Investment in marketable securities                                    25,000
  Due from affiliate                                                     96,581
  Prepaids, accrued interest and accounts receivable other               87,795
                                                                   ------------
   Total current assets                                               3,749,669
                                                                   ------------
NONCURRENT ASSETS
  Investments                                                         9,887,959
  Fixed assets, net                                                       5,806
  Deferred financing costs                                              180,642
                                                                   ------------
  Total noncurrent assets                                            10,074,407
                                                                   ------------
TOTAL ASSETS                                                       $ 13,824,076
                                                                   ============
                     LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES
  Accounts payable, accrued liabilities and other                  $    209,096
                                                                   ------------
  Total current liabilities                                             209,096
                                                                   ------------

NONCURRENT LIABILITIES
  Debenture payable--net of discount of $268,816                     15,364,383
  Derivative liability                                                  293,740
  Accrued interest payable-noncurrent                                   507,236
                                                                   ------------
  Total liabilities                                                  16,374,455
                                                                   ------------
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' DEFICIT
  Preferred stock, $.01 par value; 10,000,000 shares
    authorized Preferred stock Series A Convertible
    $0.01 par value; 100,000 shares authorized,
    95,589 shares issued and outstanding and no
    liquidation or redemption value                                         956
  Common stock, par value $0.001; 200,000,000 shares
     authorized;  11,587,693 issued and outstanding                      11,588
  Additional paid-in capital                                            198,836
  Retained earnings                                                  (2,761,759)
                                                                   ------------
  Total shareholders' deficit                                        (2,550,379)
                                                                   ------------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                        $ 13,824,076
                                                                   ============

See accompanying Notes to Condensed Consolidated Financial Statements


                                     - 3 -
--------------------------------------------------------------------------------
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                           Three Months Ended
                                                              September 30
                                                           2006           2005
                                                        -----------    -----------
<S>                                                     <C>            <C>
REVENUE
  Lease income                                          $        --    $    19,338
  Fee income                                                 19,854         34,379
  Trading gains (loss)                                      (19,903)        33,898
  Dividends from marketable securities                      107,619             --
  Interest income from notes and debenture receivable        44,818             --
                                                        -----------    -----------
  Total revenue                                             152,388         87,615
                                                        -----------    -----------


OPERATING EXPENSES
  Selling, general and administrative expenses
    (2006 and 2005 include $63,654 and
    $0, respectively, of expenses allocated
    from an affiliated entity                               489,050        275,910
   Interest expense                                         260,191         76,081
                                                        -----------    -----------
OPERATING LOSS                                             (596,853)      (264,376)
                                                        -----------    -----------

OTHER (INCOME) EXPENSE
  Net change in fair value of derivative                    (11,152)        (6,839)
  Interest and other (income) expense                       (11,647)           675
  Merger expense                                                 --        876,150
                                                        -----------    -----------
  Total other (income) expense                              (22,799)       869,986
                                                        -----------    -----------

  Loss before provision for income taxes                   (574,054)    (1,134,362)
                                                        -----------    -----------

INCOME TAX PROVISION                                             --             --
                                                        -----------    -----------
LOSS APPLICABLE TO COMMON SHARES                        $  (574,054)   $(1,134,362)
                                                        ===========    ===========

  Net loss per share for basic and diluted              $     (0.08)   $     (0.54)
                                                        ===========    ===========

  Weighted shares outstanding for basic and diluted       7,034,110      2,096,553
                                                        ===========    ===========
</TABLE>


See accompanying Notes to Condensed Consolidated Financial Statements


                                     - 4 -
--------------------------------------------------------------------------------
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                      Nine Months Ended September 30
                                                            2006            2005
                                                         -----------    -----------
<S>                                                      <C>            <C>
REVENUE
   Lease income                                          $    39,684    $    60,649
   Fee income                                                 86,009         81,492
   Trading gains (losses)                                    (66,795)        33,898
   Dividends from marketable securities                      354,054             --
   Interest income from notes and debenture receivable       217,484             --
                                                         -----------    -----------
   Total revenue                                             630,436        176,039
                                                         -----------    -----------

OPERATING EXPENSES

   Selling, general and administrative expenses
     (2006 and 2005 include $198,558 and
     $0, respectively, of expenses allocated from
     an affiliated entity)                                 1,188,385        342,427
   Interest expense                                          796,379         76,081
                                                         -----------    -----------
OPERATING LOSS                                            (1,354,328)      (242,469)
                                                         -----------    -----------

OTHER (INCOME) EXPENSE
   Net change in fair value of derivative                    (74,964)        (6,839)
   Loss on extinguishment of debenture receivable                639             --
   Other (income) expense                                    (39,882)         4,685
   Merger expense                                                 --        876,150
                                                         -----------    -----------
   Total other (income) expense                             (114,207)       873,996
                                                         -----------    -----------

   Loss before provision for income taxes                 (1,240,121)    (1,116,465)
                                                         -----------    -----------

INCOME TAX PROVISION                                              --             --
                                                         -----------    -----------
NET LOSS                                                  (1,240,121)    (1,116,465)
    Preferred dividends paid                                      --         12,000
                                                         -----------    -----------
LOSS APPLICABLE TO COMMON SHARES                         $(1,240,121)   $(1,128,465)
                                                         ===========    ===========

   Net (loss) per share for basic and diluted            $     (0.19)       4 (1.61
                                                         ===========    ===========

   Weighted shares outstanding for basic and diluted       6,539,222        699,518
                                                         ===========    ===========
</TABLE>

See accompanying Notes to Condensed Consolidated Financial Statements


                                     - 5 -
--------------------------------------------------------------------------------
<PAGE>

                               NATURAL NUTRITION, INC. AND SUBSIDIARIES
                                 (Formerly CSI Business Finance, Inc.)
                            CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                             (Unaudited)

<TABLE>
<CAPTION>
                                                                           Nine Months Ended September 30
                                                                                2006           2005
                                                                            ------------   ------------

<S>                                                                         <C>            <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                                                  $ (1,240,121)  $ (1,116,465)
  Adjustment to reconcile net income to net cash
    provided by (used in) operating activities                                 2,670,402        557,577
                                                                            ------------   ------------
      Net cash provided by (used) in operating activities                      1,430,281       (558,888)
                                                                            ------------   ------------

CASH FLOWS FROM INVESTING ACTIVITIES
  Purchases of fixed assets                                                           --         (1,000)
  Sale of asset                                                                  350,000             --
                                                                            ------------   ------------
  Purchases of minimum lease payments receivable                                      --         (25,037)
                                                                            ------------   ------------
      Net cash provided by (used in) investing activities                        350,000         (26,037)
                                                                            ------------   ------------

CASH FLOWS FROM FINANCING ACTIVITIES
  Net proceeds from sale of convertible debentures                                     --     5,371,839
  Payments on notes payable to affiliate                                        (344,282)            --
  Preferred dividends paid                                                            --        (12,000)
                                                                            ------------   ------------
  Net cash provided by (used in) financing activities                           (344,282)     5,359,839
                                                                            ------------   ------------
NET CHANGE IN CASH                                                             1,435,999      4,774,914
CASH, BEGINNING OF PERIOD                                                        204,243             --
                                                                            ------------   ------------
CASH, END OF PERIOD                                                         $  1,640,242   $  4,774,914
                                                                            ============   ============

SUPPLEMENTAL INFORMATION
  Interest paid                                                             $    432,099   $      2,755
                                                                            ============   ============
  Taxes paid                                                                $         --   $         --
                                                                            ============   ============
  Exchange of certain receivable for common stock:
    Common stock acquired
                                                                            $  9,887,959   $         --
                                                                            ============   ============
    Debentures and notes receivable exchanged                               $  9,609,283   $         --
                                                                            ============   ============
    Accrued interest receivable exchanged                                   $    278,676   $         --
                                                                            ============   ============
  Assets and liabilities assumed in merger:
    Prepaids and other                                                                --          9,992
                                                                            ============   ============
     Accounts payable and accrued liabilities                               $         --   $    262,231
                                                                            ============   ============
     Convertible debentures and notes payable                               $         --   $    547,533
                                                                            ============   ============
     Accrued interest payable                                               $         --   $     73,244
                                                                            ============   ============
     Issuance of Series A Convertible Preferred Stock                       $         --   $      1,000
                                                                            ============   ============
     Payment of debentures, notes payable and accrued interest              $         --   $    635,119
                                                                            ============   ============
     Derivative liability                                                   $         --   $    413,603
                                                                            ============   ============
     Derivative asset                                                       $         --   $     33,315
                                                                            ============   ============
     Discount on debenture payable                                          $         --   $    413,603
                                                                            ============   ============
     Premium on debenture receivable                                        $         --   $     33,315
                                                                            ============   ============
     Conversion of advances from parent to note payable                     $         --   $      4,134
                                                                            ============   ============
     Assets and liabilities paid from proceeds of convertible debentures:
        Debentures, notes payable and accrued interest payable              $         --   $  9,000,000
                                                                            ============   ============
        Deferred expenses                                                   $         --   $    575,000
                                                                            ============   ============
         Debenture, notes payable and accrued interest paid                 $         --   $    635,199
                                                                            ============   ============
         Accounts payable and accrued liabilities                           $         --   $     53,161
                                                                            ============   ============
</TABLE>


See accompanying Notes to Condensed Consolidated Financial Statements


                                     - 6 -
--------------------------------------------------------------------------------
<PAGE>

                    Natural Nutrition, Inc. and Subsidiaries
                      (Formerly CSI Business Finance, Inc.)
              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)

NOTE 1 - BASIS OF PRESENTATION

Our Condensed Consolidated Balance Sheet as of September 30, 2006, the Condensed
Consolidated  Statements  of  Operations  for the  three and nine  months  ended
September  30, 2006 and  September  30,  2005,  and the  Condensed  Consolidated
Statements  of Cash  Flows for the nine  months  ended  September  30,  2006 and
September 30, 2005 have not been audited. These statements have been prepared on
a basis that is substantially  consistent with the accounting principles applied
in our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2005.
In our opinion,  these  financial  statements  include all normal and  recurring
adjustments  necessary for a fair presentation of Natural  Nutrition,  Inc. (the
"Company") and  Subsidiaries.  The results for the three and nine months are not
necessarily indicative of the results expected for the year.

As used  herein,  the  "Company",  "management",  "we",  "our" refers to Natural
Nutrition, Inc., or Natural Nutrition, Inc. together with its subsidiaries.  The
Company's fiscal year ends on December 31st.

Certain  information  and footnote  disclosures  normally  included in financial
statements prepared in accordance with accounting  principles generally accepted
in the  United  States of  America  have been  omitted  in  accordance  with the
published rules and regulations of the U.S.  Securities and Exchange  Commission
(the  "SEC")  for  interim  financial   statements.   The  unaudited   Condensed
Consolidated Financial Statements and the notes thereto in this report should be
read in conjunction with the audited Consolidated Financial Statements and notes
thereto  included in our Annual  Report on Form 10-KSB for the fiscal year ended
December 31, 2005 (the "10-KSB").

On May 23, 2006, our Board of Directors  approved a 1 to 25 reverse common stock
split. We currently do not have sufficient  authorized shares to meet the number
of shares on the conversion of the debentures.  The Company is in the process of
amending our articles of incorporation  and bylaws to increase the number of our
authorized  shares.  All  references  to our common  stock in this  document are
stated in shares after the reverse split.

The Company,  formerly known as Health Express USA,  Inc., was  incorporated  in
Florida on July 2, 1998. On August 25, 2005,  the Company  completed the closing
of that certain Share Exchange Agreement, by and among the Company, CSI Business
Finance,  Inc., a Texas  corporation and wholly-owned  subsidiary of the Company
herein   referred  to  as  ("CSI")  and  the   shareholder   of  CSI  (the  "CSI
Shareholder").

On  September  18,  2006,  the  Company  formally  changed  its name to  Natural
Nutrition,  Inc.  and  simultaneously  migrated  from Florida to become a Nevada
corporation.

On August 25, 2005, the Company  effectively  exchanged with the CSI Shareholder
the issued and outstanding common stock of CSI in exchange for 100,000 shares of
Series A Convertible  Preferred Stock, par value $0.01 per share, of the Company
(the  "Preferred  Stock"),  and CSI  became  a  wholly-owned  subsidiary  of the
Company.  Each share of the Company's  Series A Preferred  Stock is  convertible
into 780 shares of common stock of the Company, beginning one (1) year after the
effective date of the merger.  The shares of Preferred  Stock were  subsequently
distributed  to the  shareholders  of  Corporate  Strategies,  Inc.,  the former
shareholder  of CSI. In addition,  at the  exchange  date,  4,326,861  shares of
common stock of the Company were issued to pay off notes and debentures.  If the
stockholders  of Preferred  Stock were to convert to common stock as of the date
of the merger,  they would hold  78,000,000  shares,  or ninety-two and one half
percent  (92.5%)  of the issued and  outstanding  shares of common  stock of the
Company.  This  conversion  would result in the holders of the  Preferred  Stock
effectively controlling the Company.

The holders of the  Preferred  Stock and the holders of the common  stock of the
Company vote together and not as separate classes, and the Preferred Stock shall
be counted on an "as converted"  basis,  thereby giving the holders of Preferred
Stock  control of the Company.  The  transaction  was accounted for as a reverse
acquisition  since  control of the  Company  passed to the  shareholders  of the
acquired company (CSI).

CSI, the operating  entity of the Company,  was  incorporated  primarily for the
purpose  of  engaging  in  equipment  leasing.  Subsequent  to the  merger,  the
Company's  consolidated  operations  have  expanded to include  the  purchase of
debentures  and notes  receivable,  secured  lending and  factoring to micro-cap
public and  private  companies.  The Company  also  actively  trades  marketable
securities and options with available cash, and on margin, through a third party
investment  advisor.  Because  some of our trading  involves  leveraging,  these
transactions contain a considerable amount of risk.

Since CSI was the surviving  entity of the reverse  merger,  the 2005  financial
reports  include the operating  results of the Company and its  Subsidiary  from
September 1, 2005 and CSI only from January 1, 2005 through August 31, 2005.

Our CEO is also on the Board of Directors of one of our clients. As of September
30, 2006, we have an outstanding  note receivable in the amount of $275,000 from
this client. The note receivable is separately stated on our balance sheet as of
September  30,  2006.  Subsequent  to September  30,  2006,  our CEO was elected
Chairman of our client's Board of Directors.


                                     - 7 -
<PAGE>

The  condensed  consolidated  financial  statements  include the accounts of the
Company  and  its  wholly-owned  subsidiaries.   All  significant  inter-company
accounts and transactions have been eliminated in consolidation.

NOTE 2. INCOME (LOSS) PER COMMON SHARE AND STOCK BASED COMPENSATION

Net Income (Loss) Per Common Share

In accordance with SFAS No. 128, "Earnings per Share",  basic earnings per share
are computed based on the weighted  average  shares of common stock  outstanding
during  the  periods.  Diluted  earnings  per  share are  computed  based on the
weighted  average  shares of common  stock plus the  assumed  issuance of common
stock for all potentially dilutive securities.

Our basic and diluted  shares used to compute loss per common share  amounts are
the same for both the three months and nine months ended  September 30, 2005 and
September 30, 2006.  Since we had a net loss for the three and nine months ended
September 30, 2006 and September 30, 2005, the assumed exercise of stock options
and the  conversion  of the Series A  Preferred  Stock and  secured  convertible
debentures outstanding as of September 30, 2006 would be anti-dilutive.

We  currently  do not have  sufficient  authorized  shares to meet the number of
shares on the  conversion  of the  debentures.  The Company is in the process of
amending our articles of incorporation  and bylaws to increase the number of our
authorized shares.

Stock Based Compensation

Statement  of  Financial  Accounting  Standards  No.  123(R),   "Accounting  for
Stock-Based  Compensation"  ("SFAS  123(R)"),  provides  for  the  use of a fair
value-based  method of accounting  for employee  stock  compensation.  There are
outstanding  stock options to purchase 5,695 of the Company's common stock at an
exercise  price of $1.31 per share.  These  options  expire in August  2007.  We
believe  these  options do not have a fair market value and we expect them to be
forfeited.

NOTE 3 - RESTATEMENT OF PRIOR PERIODS

We have  restated  our  financial  results  for fiscal  2005 and for the related
interim  periods therein  previously  reported.  The restatement  required us to
reissue  the report on Form 10-QSB at  September  30, 2005 and for the three and
nine months then ended. The restatements  include adjustments to (a) correct the
accounting for  convertible  debentures to recognize the effects of derivatives,
and (b) remove the beneficial  conversion  feature  previously  recorded for the
convertible debentures.

NOTE 4 - AGREEMENT IN LIEU OF FORECLOSURE

The Company completed an agreement in lieu of foreclosure (the "Agreement") with
Bio One  Corporation  ("Bio-One")  on March 22, 2006 and  received  the stock of
Interactive Nutrition  International,  Inc ("INII"), along with other assets and
claims, in return for the forgiveness of $9,887,959 in debt and accrued interest
of Bio-One and will now be treated as an investment  in INII.  INII is currently
being operated by Price  Waterhouse  Coopers as Receiver and Manager pursuant to
Section  246(2) of the  Bankruptcy  and  Insolvency  Act of Canada,  after being
requested to do so by Nesracorp Inc., Eli Nesrallah, Joseph Nesrallah and Pamela
Nesrallah  (collectively,  the  "Sellers"),  purporting  default  in  payment of
obligations   incurred  in  the   purchase   of  INII   assets  by  Bio-One.   A
Court-supervised sale of the assets has been requested by the Receiver,  and the
Company  intends to  vigorously  oppose  this and pursue all claims  against the
Sellers.  Additionally,  the  Company  has been  assigned  all rights and claims
previously  asserted against  Nesracorp Inc., Eli Nesrallah,  Joseph  Nesrallah,
Pamela Nesrallah,  Roxanne Anderson and Price Waterhouse Coopers,  Inc. filed by
INII and Bio-One in the Ontario  Superior  Court of Justice on January 13, 2005.
The Company  intends to pursue some or all of the previous  claims in the filing
of January 13, 2005 in Ontario  Superior Court of Justice,  as the stock of INII
and these claims,  as well as others,  have been assigned to the Company as part
of the Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando,  Florida against Eli Nesrallah,  Joseph Nesrallah and Pamela Nesrallah,
alleging,  among other claims,  breach of fiduciary duty to INII. As of the date
of this filing,  the Florida  action has been abated  pending the outcome of the
results of our action  filed in Canada.  No reserve has been  established  for a
loss on this transaction, as the Company believes its claims are meritorious and
have a reasonable  probability of prevailing in a Court of law. However,  should
the  Company  fail to  prevail or settle its claims  against  the  Sellers,  the
Company may be required to write down its entire  investment  of  $9,537,959  in
INII.

As a result of the above  foreclosure,  the  Company has  recorded a  $9,887,959
investment in the INII stock consisting of an $8,500,000  debenture  receivable,
$1,109,283 notes receivable and $278,676 of accrued  interest  receivable.  This
amount has been reduced by $350,000 reflecting the sale of an asset.

NOTE 5 - DERIVATIVE FINANCIAL INSTRUMENTS

The derivatives for the debenture  payable have been accounted for in accordance
with Statement of Financial  Accounting Standards Statement No. 133, "Accounting
for  Derivative  Instruments  and  Hedging  Activities",  ("SFAS  133")  and the
Emerging  Issues Task Force  Abstract  No.  00-19,  "Accounting  for  Derivative
Financial  Instruments  Indexed to, and Potentially  Settled in, a Company's Own
Stock", ("EITF No. 00-19").


                                     - 8 -
<PAGE>

We have  determined  that the following  instrument  has  derivatives  requiring
evaluation and accounting  under the relevant  guidance  applicable to financial
derivative:

      o     Cornell Convertible Debenture (the "Convertible Debenture"), issued
            on September 9, 2005 in the face amount of $15,635,199.

Management has  determined  that the above  debenture has embedded  derivatives.
These embedded  derivatives have been bifurcated from their respective host debt
contracts and accounted  for as a derivative  liability in accordance  with EITF
00-19. When multiple  derivatives exist within the Convertible  Debenture,  they
have been bundled together as a single hybrid compound  instrument in accordance
with SFAS No. 133  Derivatives  Implementation  Group  Implementation  Issue No.
B-15,  "Embedded  Derivatives:   Separate  Accounting  for  Multiple  Derivative
Features Embedded in a Single Hybrid Instrument".

The embedded derivatives within the Convertible  Debenture have been recorded at
fair value at the date of  issuance;  and are  marked-to-market  each  reporting
period  with  changes in fair value  recorded  to our income  statement  as "Net
change in fair value of derivative". We utilized a third party valuation firm to
fair   value   the   embedded    derivatives   using   a   layered    discounted
probability-weighted  cash flow approach. The fair value model utilized to value
the  various  embedded  derivatives  in  the  Convertible  Debenture,  comprises
multiple probability-weighted scenarios under various assumptions reflecting the
economics of the  Convertible  Debenture,  such as the risk-free  interest rate,
expected  issuer stock price and  volatility,  likelihood of  conversion  and or
redemption and likelihood  default status and timely  registration.  The Company
used this model for the derivative valuations at September 30, 2006.

The fair value of the  derivative  liability  is  subject to the  changes in the
trading value of our common stock,  as well as other factors.  As a result,  our
financial  statements  may fluctuate from  quarter-to-quarter  based on factors,
such as the price of our common  stock at the balance  sheet date and the amount
of shares converted by the note holders.  Consequently,  our financial  position
and results of operations may vary from  quarter-to-quarter  based on conditions
other than our operating revenues and expenses.

The  conversion  feature,  reset  provision  and the  Company's  optional  early
redemption  right  have been  bundled  together  as a single  compound  embedded
derivative liability, and using a layered discounted  probability-weighted  cash
flow approach, was initially fair valued at $413,603 at September 9, 2005. Using
the same  methodology,  the single compound  embedded  derivative  liability was
valued at  $293,740  at  September  30,  2006.  The  change in fair value of the
derivative  liability was a decrease of $11,152 from our prior reporting period,
and has been  classified  as "net  change in fair  value of  derivative"  in our
Condensed  Consolidated  Statements of Operations  for the three and nine months
ended September 30, 2006.

The Company had a debenture receivable which was extinguished on March 22, 2006.
The derivative instrument related to the debenture receivable was initially fair
valued at $33,315 upon  acquisition  at September 9, 2005.  The single  compound
embedded derivative  receivable was valued at $26,273 at March 22, 2006. For the
period  January  1 through  March  22,  2006,  the  change in fair  value of the
derivative  asset was an increase  of $104,  which has been  classified  as "net
change in fair value of derivative".

As result of the  foreclosure  discussed on Note 4, the  derivative  asset and a
premium  on  the  debenture  receivable  was  written  off  and a $639  loss  on
extinguishment of debenture receivable was recorded during the nine months ended
September 30, 2006.


ITEM 2 .      MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS

This  Quarterly  Report on Form  10-QSB,  and the  accompanying  MD&A,  contains
forward-looking  statements.  Statements  contained in this report about Natural
Nutrition,  Inc.'s future outlook,  prospects,  strategies and plans,  and about
industry  conditions and demand for our financial services are  forward-looking.
All statements that express  belief,  expectation,  estimates or intentions,  as
well as those that are not statements of historical  fact, are forward  looking.
The words "proposed,"  "anticipates,"  "anticipated," "will," "would," "should,"
"estimates"  and similar  expressions  are intended to identify  forward-looking
statements.  Forward-looking  statements represent our reasonable belief and are
based on our current expectations and assumptions with respect to future events.
While we believe our expectations  and assumptions are reasonable,  they involve
risks and  uncertainties  beyond our control that could cause the actual results
or outcome to differ  materially from the expected results or outcome  reflected
in our forward-looking  statements.  In light of these risks,  uncertainties and
assumptions,  the forward-looking  events discussed in this quarterly report may
not  occur.  Such  risks and  uncertainties  include,  without  limitation,  our
successful efforts in the outcome of our litigation concerning our investment in
INII,  our  success in trading  marketable  securities,  our ability to maintain
contracts that are critical to our  operations,  actual  customer demand for our
financing and related services, collection of accounts and notes receivable, our
ability  to obtain  and  maintain  normal  terms with our  vendors  and  service
providers and  conditions in the capital  markets and equity  markets during the
periods covered by the forward-looking statements.

 The  forward-looking  statements  contained in this report speak only as of the
date  hereof.  We  undertake  no  obligation  to  publicly  update or revise any
forward-looking  statements,  whether  as a result  of new  information,  future
events or any other  reason.  All  forward-looking  statements  attributable  to
Natural  Nutrition,  Inc.  or any  person  acting on its  behalf  are  expressly
qualified in their entirety by the cautionary  statements  contained or referred
to in our annual report filed on Form 10-KSB and in our future periodic  reports
filed with the SEC. The following M,D&A should be read in conjunction with these
unaudited Condensed  Consolidated  Financial  Statements of the Company, and the
related notes thereto  included  elsewhere  herein,  and in conjunction with our
audited financial statements, together with footnotes and the M,D&A, in our 2005
annual report filed on Form 10-KSB with the Securities  Exchange Commission (the
"SEC").


                                     - 9 -
<PAGE>

Overview

On August 25, 2005,  Health  Express USA, Inc., a Florida  corporation,  entered
into a share  exchange  agreement  with  CSI  Business  Finance,  Inc.,  a Texas
corporation ("CSI") and the shareholder of CSI (Corporate Strategies, Inc.). The
transaction  is being  reflected as a reverse  acquisition  since control of the
Company has passed to the shareholders of Corporate Strategies, Inc. ("Corporate
Strategies").  The  Company  was  subsequently  renamed in 2005 to CSI  Business
Finance,  Inc.  (the  Florida  corporation).  In  September of 2006 CSI Business
Finance,  Inc. changed its name to Natural  Nutrition,  Inc. and  simultaneously
migrated from Florida to Nevada.

On May 23, 2006, our Board of Directors  approved a 1 to 25 reverse common stock
split. We currently do not have sufficient  authorized shares to meet the number
of shares on the conversion of the debentures.  The Company is in the process of
amending our articles of incorporation  and bylaws to increase the number of our
authorized  shares.  All  references  to our common  stock in this  document are
stated in shares after the reverse split.

At present our Company,  through our operating  subsidiary,  primarily generates
cash  and  revenue  from  financing  and  investing  activities.  To date  these
activities have included  equipment  leasing,  factoring,  brokerage  activities
earned in originating and selling business leases,  providing short term secured
lending,  and investing in marketable  securities.  We commonly  purchase  notes
receivable instruments and blocks of common stock from publicly traded micro cap
issuers and  individual  holders of notes and publicly  traded common stock.  We
offer  individual  issuers and holders in need of liquidity the  opportunity  to
sell these notes or  securities  quickly and easily.  We believe  that gains are
possible in holding these notes and  securities  and then selling the securities
or  collecting  the notes  purchased  in the normal  course of  business  over a
reasonable period of time.  Competition for the services we provide comes mainly
from financial  institutions that provide factoring  services,  equipment leases
and  small  business  loans,  many of  which  have  substantially  more  capital
resources than our Company.

We also actively trade  marketable  securities and options with available  cash,
and on margin,  through a third party  investment  advisor.  Because our trading
involves leveraging, these transactions contain a considerable amount of risk.

Management of the Company  mitigates its risk in lending by securing  loans with
pledged assets (collateral) that, when liquidated, have a reasonable probability
of realizing  proceeds that would retire the liability.  In some  instances,  we
obtain personal  guarantees from  individuals of net worth which are adequate to
repay the  liability  in the event of default.  Additionally,  in the example of
public company finance, we utilize conversion features at a substantial discount
to the market in the event of  default  that  would  enable us realize  adequate
proceeds  from the sale of the  borrower's  stock to repay the  liability to the
Company. Over the long term, management would like to concentrate its efforts on
growing the business of INII, our largest asset.

The Company completed an agreement in lieu of foreclosure (the "Agreement") with
Bio One  Corporation  ("Bio-One")  on March 22, 2006 and  received  the stock of
Interactive Nutrition  International,  Inc ("INII"), along with other assets and
claims, in return for the forgiveness of $9,887,959 in debt and accrued interest
of Bio-One and will now be treated as an investment  in INII.  INII is currently
being operated by Price  Waterhouse  Coopers as Receiver and Manager pursuant to
Section  246(2) of the  Bankruptcy  and  Insolvency  Act of Canada,  after being
requested to do so by Nesracorp Inc., Eli Nesrallah, Joseph Nesrallah and Pamela
Nesrallah  (collectively,  the  "Sellers"),  purporting  default  in  payment of
obligations   incurred  in  the   purchase   of  INII   assets  by  Bio-One.   A
Court-supervised sale of the assets has been requested by the Receiver,  and the
Company  intends to  vigorously  oppose  this and pursue all claims  against the
Sellers.  Additionally,  the  Company  has been  assigned  all rights and claims
previously  asserted against  Nesracorp Inc., Eli Nesrallah,  Joseph  Nesrallah,
Pamela Nesrallah,  Roxanne Anderson and Price Waterhouse Coopers,  Inc. filed by
INII and Bio-One in the Ontario  Superior  Court of Justice on January 13, 2005.
The Company  intends to pursue some or all of the previous  claims in the filing
of January 13, 2005 in Ontario  Superior Court of Justice,  as the stock of INII
and these claims,  as well as others,  have been assigned to the Company as part
of the Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando,  Florida against Eli Nesrallah,  Joseph Nesrallah and Pamela Nesrallah,
alleging,  among other claims,  breach of fiduciary duty to INII. As of the date
of this filing,  the Florida  action has been abated  pending the outcome of the
results of our action  filed in Canada.  No reserve has been  established  for a
loss on this transaction, as the Company believes its claims are meritorious and
have a reasonable  probability  of prevailing in a Court of law. We have reduced
our  investment  by $350,000  for proceeds  from the sale of an asset.  However,
should the Company fail to prevail or settle its claims against the Sellers, the
Company may be required to write down its entire  investment  of  $9,537,959  in
INII.

As a result of the above  foreclosure,  the  Company has  recorded a  $9,887,959
investment in the INII stock consisting of an $8,500,000  debenture  receivable,
$1,109,283 notes receivable and $278,676 of accrued interest receivable. We have
reduced our investment by $350,000 for proceeds from the sale of an asset.

Recent Accounting Pronouncements

In July 2006,  the FASB  issued  FIN 48,  which  clarifies  the  accounting  for
uncertainty in tax positions.  This Interpretation requires that we recognize in
our financial statements, the impact of a tax position, if that position is more
likely than not of being  sustained on audit,  based on the technical  merits of
the position.  The provisions of FIN 48 are effective as of the beginning of our
2007  fiscal  year,  with the  cumulative  effect of the  change  in  accounting
principle  recorded  as an  adjustment  to  opening  retained  earnings.  We are
currently evaluating the impact of adopting FIN 48 on our financial statements.


                                     - 10 -
<PAGE>

RESULTS OF OPERATIONS

Three Months Ended September 30, 2006 and September 30, 2005

We had no leasing income for the three months ended September 30, 2006.  Leasing
income for the three  months  ended  September  30,  2005 was  $19,338.  We will
continue to seek leasing  opportunities  in the future,  however this is not the
primary focus of management,  or the Company's  resources.  We are  continuously
seeking turn-around  opportunities as these opportunities arise. Fee income from
brokerage fees earned in originating  and selling  business leases and loans was
$19,854 for the three months  ended  September  30, 2006 versus  $34,379 for the
three months ended  September 30, 2005.  During the quarter ended  September 30,
2006,  the  Company  funded  short-term  loans  to  four  new  clients  totaling
approximately $758,000.

Interest  income was  $44,818  for the three  months  ended  September  30, 2006
compared to zero dollars ($0) for the three  months  ended  September  30, 2005.
Interest income was derived mainly from notes receivable relating to receivables
factoring and  investments.  We expect interest income to increase in the future
since the  Company has  increased  working  capital  availability  for  business
lending and factoring.  Dividend  income was $107,619 for the three months ended
September  30, 2006  compared to zero  dollars  ($0) for the three  months ended
September  30,  2005.   Dividend  income  is  primarily   derived  from  various
investments in marketable  securities.  We actively trade marketable  securities
and consider trading to be a significant source of future revenue. For the three
months ended  September  30, 2006,  we recorded net trading  losses from various
investments  in  marketable  securities  in the amount of $19,903  ($108,507  in
realized trading losses and $88,604 in unrealized  trading gains). For the three
months ended  September  30, 2005,  we recorded  $33,898 net trading  gains from
various investments in marketable  securities ($32,719 in realized trading gains
and $1,179 in unrealized trading gains).

We have not yet reached the size to benefit  from  separate  office  space and a
dedicated  staff.  Our Company  shares  office space and certain  administrative
functions  and staff with an affiliated  company.  Costs are allocated for these
shared functions based on an estimate of time usage.

Selling,  general and administrative expenses were $489,050 for the three months
ended  September 30, 2006 versus  $275,910 for the three months ended  September
30, 2005. Professional fees of $249,337 associated with the Company's investment
in INII as more fully described in Note 4 and our legal  proceedings  section to
the  Condensed  Consolidated  Financial  Statements  and  salaries  expense  and
allocated  overhead of $175,612  comprised the majority of these  expenses.  The
remainder  of our  selling,  general and  administrative  expenses for the three
months ended  September 30, 2006 consist  primarily of business  development and
other ordinary expenses necessary for the operation of the Company. Salaries and
benefits were $198,697 for the three months ended September 30, 2005,  while the
remainder of the expenses  incurred  were for allocated  expenses,  professional
fees and other ordinary  office related  expenses.  The increase in salaries and
benefits is due to officer's salaries incurred since the August 2005 merger.

We incurred  interest  expense of $260,191 for the three months ended  September
30, 2006  compared to $76,081 for the three  months  ended  September  30, 2005.
Interest  primarily relates to the expense  associated with the $15,635,199 five
percent (5%) convertible  debenture entered into in September 2005 to fund INII,
anticipated growth of the Company and interest on our margin loan.

We mark to market our derivative  liability on a quarterly  basis. For the three
months  ended  September  30, 2006,  the net change in fair value of  derivative
amounted to $11,152 of other income.

For the three months ended  September 30, 2005, we recorded a merger  expense in
the amount of $876,160 in  association  with the Share  Exchange  Agreement more
fully described in Note 1.

Nine Months Ended September 30, 2006 and September 30, 2005

Lease income for the nine months ended  September 30, 2006 was $39,684  compared
with $60,649 for the nine months ended  September  30, 2005. We will continue to
seek leasing opportunities in the future,  however this is not the primary focus
of  management,   or  the  Company's  resources.  We  are  continuously  seeking
turn-around   opportunities  as  these  opportunities  arise.  Fee  income  from
brokerage  fees  earned in  originating  and selling  business  leases and loans
remained  relatively constant for the comparable nine months ended September 30,
2006 and 2005.  Fee income was $86,009 for the nine months ended  September  30,
2006 versus  $81,492 for the nine months ended  September 30, 2005. For the nine
months ended September 30, 2006, the Company funded  short-term loans to six new
clients totaling approximately $1,595,000.

Interest  income was  $217,484  for the nine  months  ended  September  30, 2006
compared to $0 for the nine months ended September 30, 2005. Interest income was
derived  mainly from notes  receivable  relating to  receivables  factoring  and
investments   as  well  as  interest  from  a  debenture  and  notes  that  were
subsequently  traded on March 22, 2006 for stock in a Canadian subsidiary of the
maker of the  debentures.  We expect  interest  income to increase in the future
since the  Company has  increased  working  capital  availability  for  business
lending and  factoring.  Dividend  income was $354,054 for the nine months ended
September  30, 2006  compared  to zero  dollars  ($0) for the nine months  ended
September  30,  2005.   Dividend  income  is  primarily   derived  from  various
investments in marketable  securities.  For the nine months ended  September 30,
2006,  the Company  recorded  net trading  losses from  various  investments  in
marketable  securities in the amount of $66,795.  These losses were attributable
to sharp, short term losses in value of certain portfolio segments that were not
properly hedged against sudden  decreases in value. We actively trade marketable
securities and consider  trading to be a source of future  revenue.  The Company
has taken steps to protect its portfolio with the use of put and call options to
limit the risk of losses in the future, while maximizing upside potential.


                                     - 11 -
<PAGE>

We have not yet reached the size to benefit  from  separate  office  space and a
dedicated  staff.  Our Company  shares  office space and certain  administrative
functions  and staff with an affiliated  company.  Costs are allocated for these
shared functions based on an estimate of time usage.

Selling, general and administrative expenses were $1,188,385 for the nine months
ended September 30, 2006 versus $342,427 for the nine months ended September 30,
2005.  Professional fees of $645,734 associated with the Company's investment in
INII, as more fully described in Note 4 and our legal proceedings section to the
Condensed Consolidated Financial Statements,  and salaries expense and allocated
overhead of totaling  $402,905  comprised  the majority of these  expenses.  The
remainder  of our  selling,  general and  administrative  expenses  for the nine
months ended  September 30, 2006 consist  primarily of business  development and
other ordinary expenses necessary for the operation of the Company. Salaries and
benefits were $230,803 for the nine months ended  September 30, 2005,  while the
remainder  of the  expenses  incurred  were  for  allocated  overhead  expenses,
professional  fees and other ordinary office related  expenses.  The increase in
salaries  and benefits is due to officer's  salaries  incurred  since the August
2005 merger.

Interest  expense was  $796,379  for the nine months  ended  September  30, 2006
compared to $76,081 for the nine  months  ended  September  30,  2005.  Interest
primarily  relates to the expense  associated with the $15,635,199  five percent
(5%)  convertible  debenture  entered  into in  September  2005  to  fund  INII,
anticipated growth of the Company and interest on our margin loan.

We mark to market our derivative  liability on a quarterly  basis.  For the nine
months  ended  September  30, 2006,  the net change in fair value of  derivative
amounted to $74,964 of other income.

For the nine months ended  September 30, 2005,  we recorded a merger  expense in
the amount of $876,160 in  association  with the Share  Exchange  Agreement more
fully described in Note 1 to these financial statements.

Liquidity and Capital Resources

Operating Activities

We  incurred a net loss for the nine  months  ended  September  30,  2006 in the
amount of  $1,240,121.  During the nine months ended  September  30,  2006,  our
operations  provided cash flow in the amount of  $1,430,281.  Our operating cash
flow was provided  primarily by an increase in the value of our  investments  in
marketable  securities  ($6,021,719)  offset by a  reduction  of our  associated
margin  loan  ($2,936,194),   changes  in  minimum  lease  payments   receivable
($241,532) and debentures receivable ($519,238).  Our decreases in net operating
cash  were  primarily  a result of  changes  in the  amount of notes  receivable
($1,414,195) used to fund short term loans for six new clients.
Investing Activities

Investing Activities

We realized $350,000 in proceeds from the sale of assets. The asset was included
as a part of our  investment  in  INII.  A  receivable  for this  asset  was not
recorded when our original  investment  in INII was made.  The proceeds from the
collection of this loan were charged to our  investment in INII.  These proceeds
were  immediately  used to pay a  portion  of the  accrued  interest  due on our
debenture payable.

Financing Activities

For the nine months ended  September 30, 2006, we made $344,282 of payments on a
note to an affiliate. The loan was fully repaid in the second quarter of 2006.

Our CEO is also on the Board of Directors of one of our clients. As of September
30, 2006, we have an outstanding  note receivable in the amount of $275,000 from
this client. The note receivable is separately stated on our balance sheet as of
September  30,  2006.  Subsequent  to September  30,  2006,  our CEO was elected
Chairman of our client's Board of Directors.

The Company had working  capital in the amount of  $3,540,573  at September  30,
2006.  Included  in our  working  capital  is  $1,708,386  of short  term  notes
receivable.  For the nine months ended September 30, 2006, we funded  short-term
loans to six new clients totaling approximately $1,595,000.


                                     - 12 -
<PAGE>

Our cash flows for the periods are summarized below:

<TABLE>
<CAPTION>
                                                         Nine Months Ended     Nine Months Ended
                                                         September 30, 2006    September 30, 2005
                                                         ------------------    ------------------
<S>                                                      <C>                   <C>
Net cash provided (used) in                              $        1,430,281    $         (558,888)
  operating activities
Net cash used in investing activities                    $          350,000    $           26,037
Net cash provided  (used) in financing activities        $         (344,282)   $        5,359,839
</TABLE>

Our cash increased $1,435,999 since December 31, 2005

Management  believes  the Company has  adequate  working  capital and cash to be
provided from  operating  activities to fund current  levels of  operations.  We
anticipate  that our company will grow. As our business grows we believe that we
will have to raise  additional  capital in the  private  debt and public  equity
markets to fund our investments.

Off-Balance Sheet Arrangements

The Company had no off-balance  sheet  arrangements or guarantees of third party
obligations at September 30, 2006.

Inflation

The  Company  believes  that  inflation  has not  had a  significant  impact  on
operations since inception.


 ITEM 3. CONTROLS AND PROCEDURES

(A) Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that
information  required to be  disclosed  in reports  filed  under the  Securities
Exchange  Act  of  1934,  as  amended,  is  recorded,   processed,   summarized,
accumulated and  communicated to the Company's  management,  including its Chief
Executive Officer ("CEO") and Chief Financial  Officer ("CFO"),  as appropriate,
to allow timely decisions regarding required disclosure.
As of the end of the period  covered by this report,  the  Company's  management
carried out an evaluation,  under the supervision and with the  participation of
the  Company's  Chief  Executive  Officer  ("CEO") and Chief  Financial  Officer
("CFO"),  of the  effectiveness  of the design and  operation  of the  Company's
system of disclosure  controls and  procedures  pursuant to the  Securities  and
Exchange Act, Rule 13a-15(e) and 15d-15(e) under the Exchange Act). Based on the
material  weaknesses  described  herein the Company's CEO and CFO have concluded
that the Company's disclosure controls and procedures were not effective,  as of
the  date of  that  evaluation,  for  the  purposes  of  recording,  processing,
summarizing  and  timely  reporting  of  material  information  required  to  be
disclosed  in  reports  filed  by the  Company  under  the  Exchange  Act.  More
specifically,  our failure to maintain  effective  controls over the  selection,
application  and  monitoring of our  accounting  policies to assure that certain
transactions were accounted for in conformity with generally accepted accounting
principles resulted in a failure during 2005 to record an appropriate derivative
liability,  deemed interest expense associated with the derivative liability and
related charges  associated  with changes in the value of embedded  derivatives,
arising from the issuance  during 2005 and a failure  during the last quarter of
2005 to properly disclose hedging activities.

(B) Changes in Internal Controls over Financial Reporting
In connection with the evaluation of the Company's  internal controls during the
Company's last fiscal quarter covered by this report,  the Company's CEO and CFO
have  determined that there were no changes to the Company's  internal  controls
over financial reporting that have materially affected, or are reasonably likely
to materially effect, the Company's internal controls over financial reporting.

Material Weaknesses Identified

In connection with the audit of our  consolidated  financial  statements for the
fiscal  year  ended  December  31,  2005,  our  independent   registered  public
accounting firm informed us that we have significant  deficiencies  constituting
material weaknesses. As defined by the Public Company Accounting Oversight Board
Auditing Standard No. 2, a material weakness is a significant control deficiency
or a combination of significant control  deficiencies that result in there being
more than a remote  likelihood  that a  material  misstatement  in the annual or
interim  financial  statements  will not be prevented or detected.  The specific
problems  identified  by the  auditor  were (1) lack of  segregation  of  duties
necessary to maintain proper checks and balances between functions,  (2) failure
of  internal  personnel  to  adequately  communicate  the  scope  and  nature of
non-routine transactions, and (3) applications of improper accounting principles
to  derivative  financial  instruments.  The  absence  of  qualified  full  time
accounting personnel was a contributing factor to the problems identified by the
auditor.  The  specific  circumstances  giving  rise to the  weaknesses  include
utilizing  the  services  of  contract  accountants  on a part time basis in the
absence of  internal  accounting  personnel.  As a result of the absence of full
time  in-house  accounting  personnel  and the failure of in-house  personnel to
adequately communicate information to the outside contract accountants,  certain
journal  entries  required  during 2004 and 2005 were not made until the time of
the audit when the need for such entries was identified by the auditor.


                                     - 13 -
<PAGE>

As a result of our  review  of the items  identified  by our  auditors,  we have
concluded that our previous derivative  accounting policies were incorrect and a
communication failure resulted in not properly disclosing hedging activities.

In light of the above, we have restated our  consolidated  financial  statements
for the third quarter of 2005 to correct our accounting for derivatives.

The  effects  of  the  aforementioned  weaknesses  related  to the  closing  and
preparation of the financial  statements  were corrected by management  prior to
the issuance of this Quarterly Report on Form 10-QSB.

Remediation Plan regarding the Material Weaknesses

Because of our size, we share our accounting  staff with an affiliated  company.
The  accounting  department  is  comprised  of our Chief  Financial  Officer,  a
part-time Controller,  an accounting manager and a data entry clerk, all of whom
are considered contract employees since they are on the payroll of its affiliate
and we reimburse our affiliate for the our share of the costs.

Management is actively  engaged in  remediation  efforts to address the material
weaknesses identified in the Company's internal control over financial reporting
as of June 30, 2006.  These on-going  remediation  efforts,  outlined below, are
specifically   designed  to  address  the  material  weaknesses   identified  by
Management  and  to  improve  and  strengthen  the  Company's   overall  control
environment.

The  Company has taken the  following  steps to address  the  specific  problems
identified by the auditors:

      o     Our previous contract CFO was part time. Due to family health issues
            he was unable to devote full time to this  position and has resigned
            as contract CFO and has become a part time contract controller.  Our
            affiliate  has  hired  a  Chief  Financial  Officer  and a  contract
            full-charge  bookkeeper  to  allow  us  to  properly  implement  the
            segregation  of duties  necessary  to maintain  checks and  balances
            between accounting and executive functions.


      o     All  non-routine  transactions  will  be  reviewed  by our  CFO  and
            accounting manager before they are completed.

      o     Our CFO will  monitor  our  accounting  policies  to  insure  proper
            accounting for financial  derivatives and other unusual transactions
            on an ongoing basis.

During the quarter ended December 31, 2005, a full time  accounting  manager was
hired by our  affiliate.  We believe  that in  conjunction  with the hiring of a
contract  full  charge  bookkeeper,  we will be able to  materially  improve our
internal controls over financial reporting.

The Company  continues its efforts to remediate  control  weaknesses and further
improve and strengthen its internal  control over financial  reporting under the
direction of the CEO and the CFO.

                           PART II - OTHER INFORMATION

ITEM 1 . LEGAL PROCEEDINGS


The Company completed an agreement in lieu of foreclosure (the "Agreement") with
Bio One  Corporation  ("Bio-One")  on March 22, 2006 and  received  the stock of
Interactive Nutrition  International,  Inc ("INII"), along with other assets and
claims, in return for the forgiveness of $9,887,959 in debt and accrued interest
of Bio-One and will now be treated as an investment  in INII.  INII is currently
being operated by Price  Waterhouse  Coopers as Receiver and Manager pursuant to
Section  246(2) of the  Bankruptcy  and  Insolvency  Act of Canada,  after being
requested to do so by Nesracorp Inc., Eli Nesrallah, Joseph Nesrallah and Pamela
Nesrallah  (collectively,  the  "Sellers"),  purporting  default  in  payment of
obligations   incurred  in  the   purchase   of  INII   assets  by  Bio-One.   A
Court-supervised sale of the assets has been requested by the Receiver,  and the
Company  intends to  vigorously  oppose  this and pursue all claims  against the
Sellers.  Additionally,  the  Company  has been  assigned  all rights and claims
previously  asserted against  Nesracorp Inc., Eli Nesrallah,  Joseph  Nesrallah,
Pamela Nesrallah,  Roxanne Anderson and Price Waterhouse Coopers,  Inc. filed by
INII and Bio-One in the Ontario  Superior  Court of Justice on January 13, 2005.
The Company  intends to pursue some or all of the previous  claims in the filing
of January 13, 2005 in Ontario  Superior Court of Justice,  as the stock of INII
and these claims,  as well as others,  have been assigned to the Company as part
of the Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando,  Florida against Eli Nesrallah,  Joseph Nesrallah and Pamela Nesrallah,
alleging,  among other claims,  breach of fiduciary duty to INII. As of the date
of this filing,  the Florida  action has been abated  pending the outcome of the
results of our action  filed in Canada.  No reserve has been  established  for a
loss on this transaction, as the Company believes its claims are meritorious and
have a reasonable  probability of prevailing in a Court of law. However,  should
the  Company  fail to  prevail or settle its claims  against  the  Sellers,  the
Company may be required to write down its entire  investment  of  $9,537,959  in
INII.


                                     - 14 -
<PAGE>

ITEM 2 . UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3 . DEFAULTS UPON SENIOR SECURITIES

None.


ITEM 4 . SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.


ITEM 5 . OTHER INFORMATION

None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (A) Documents filed as a part of this
report.

EXHIBIT 31.1 Officer's Certification Pursuant to Section 302

EXHIBIT 32.1 Certificate  pursuant to 18 U.S.C. Section 1350 as adopted pursuant
             to Section 906 of the Sarbanes-Oxley Act of 2002

(B) Current Reports filed on Form 8-K:

None


                                     - 15 -
<PAGE>


                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the Company has caused
this  Quarterly  Report  on  Form  10-QSB  to be  signed  on its  behalf  by the
undersigned, thereunto duly authorized.

 Date: November 14, 2006                       Natural Nutrition, Inc.
                                         (Formerly CSI Business Finance, Inc.)
                                         -------------------------------------
                                                     (Registrant)

                                                /s/ Timothy J Connolly
                                         -------------------------------------
                                                 Timothy J. Connolly
                                               Chief Executive Officer



 Date: November 14, 2006                       Natural Nutrition, Inc.
                                         (Formerly CSI Business Finance, Inc.)
                                         -------------------------------------
                                                     (Registrant)

                                                 /s/ Wm Chris Mathers
                                         -------------------------------------
                                                   Wm Chris Mathers
                                               Chief Financial Officer

                                     - 16 -
<PAGE>